# Safety and Efficacy Study of CitraFleet (Sodium Picosulphate) as an Evacuating Treatment Prior to Colonoscopy.

> **NCT01065857** · PHASE3 · COMPLETED · sponsor: **Laboratorios Casen-Fleet S.L.U.** · enrollment: 547 (estimated)

## Conditions studied

- Subjects Undergoing a Complete Exploratory Diagnostic Colonoscopy for the First Time.

## Interventions

- **DRUG:** Sodium picosulphate, light magnesium oxide and anhydride citric acid.
- **DRUG:** Polyethylene glycol, KCl, NaCl, sodium sulphate anhydrous and sodium bicarbonate.

## Key facts

- **NCT ID:** NCT01065857
- **Lead sponsor:** Laboratorios Casen-Fleet S.L.U.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-06
- **Final completion:** 2011-02
- **Target enrollment:** 547 (ESTIMATED)
- **Last updated:** 2011-04-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01065857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01065857, "Safety and Efficacy Study of CitraFleet (Sodium Picosulphate) as an Evacuating Treatment Prior to Colonoscopy.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01065857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*